Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Stefanie Reiermann"'
Autor:
Stefan Reuter, Stefanie Reiermann, Viola Malyar, Katharina Schütte-Nütgen, Renè Schmidt, Hermann Pavenstädt, Holger Reinecke, Barbara Suwelack
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0161927 (2016)
Cardiovascular disease (CVD) is the leading cause of death after renal transplantation with a high prevalence in dialysis patients. It is still a matter of debate how to assess the cardiovascular risk in kidney transplant candidates. Several approach
Externí odkaz:
https://doaj.org/article/529962cbcc094379858bed023ac80c0b
Autor:
Lars Stegger, Joachim Bautz, Kambiz Rahbar, Stefan Reuter, Barbara Suwelack, Michael Schäfers, Stefanie Reiermann, Jörg Stypmann, H Pavenstädt
Publikováno v:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
Background We aimed to compare the prognostic value of myocardial perfusion scintigraphy (MPS) and dobutamine stress echocardiography (DSE) in patients with end-stage renal disease (ESRD) without known coronary artery disease. Methods Two-hundred twe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc46f6095f5662930ab5355a2ac8ce5
https://pubmed.ncbi.nlm.nih.gov/34750727
https://pubmed.ncbi.nlm.nih.gov/34750727
Autor:
Nicole Muschol, Katharina Stumpfe, Sima Canaan-Kühl, Claudia Sommer, Thomas Duning, Eva Brand, Daniela Blaschke, W. Alexander Mann, Christine Kurschat, Nurcan Üçeyler, Nesrin Karabul, Dan Liu, Stefanie Reiermann, Peter Nordbeck, Anibh M. Das, Malte Lenders, Monica Patten, Jessica Kaufeld, Christoph Kampmann, Jens Gaedeke, Jonas Müntze, Stefan-Martin Brand, Markus Cybulla, Christian Pogoda, Julia B. Hennermann
Publikováno v:
Clinical pharmacology and therapeutics. 108(2)
Fabry's disease (FD) is an X-linked lysosomal storage disorder caused by the deficient activity of the lysosomal enzyme alpha-galactosidase A (alpha-Gal A) leading to intracellular accumulation of globotriaosylceramide (Gb3). Patients with amenable m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5adac12f2836176d39f9cf2fbe9beed8
https://pubmed.ncbi.nlm.nih.gov/32198894
https://pubmed.ncbi.nlm.nih.gov/32198894
Autor:
Timo Gottschling, Stefan-Martin Brand, Daniela Blaschke, Jörg Stypmann, Johannes Krämer, Stefanie Reiermann, Sima Canaan-Kühl, Nurcan Üçeyler, Stefan Störk, Claudia Sommer, Thomas Duning, Malte Lenders, Frank Weidemann, Christoph Wanner, Peter Nordbeck, Eva Brand
Publikováno v:
Nephrology Dialysis Transplantation. 33:1362-1372
Background Fabry patients on reduced dose of agalsidase-beta or after switch to agalsidase-alfa show a decline in estimated glomerular filtration rate (eGFR) and an increase of the Mainz Severity Score Index. Methods In this prospective observational
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e3bdff1c3fa94433d17554421c166e5
https://doi.org/10.1093/ndt/gfx319
https://doi.org/10.1093/ndt/gfx319
Autor:
Jörg Stypmann, Stefan Störk, Nurcan Üçeyler, Alice Krebs, Stefan-Martin Brand, Michael Schelleckes, Markus Niemann, Eva Brand, Christoph Wanner, Frank Weidemann, Thomas Duning, Stefanie Reiermann, Johannes Krämer, Sima Canaan-Kühl, Claudia Sommer, Malte Lenders, Hans Guerrero González
Publikováno v:
Journal of the American Society of Nephrology. 25:837-849
Because of the shortage of agalsidase-beta in 2009, many patients with Fabry disease were treated with lowerdosesorwereswitchedtoagalsidase-alfa.Thisobservationalstudyassessedend-organdamageand clinical symptoms during dose reduction or switch to aga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75d1ee1d3c5333bb7705874c8144bdc6
https://doi.org/10.1681/asn.2013060585
https://doi.org/10.1681/asn.2013060585
Publikováno v:
NDT Plus
Background. A number of studies suggested that the type of dialysis membrane is associated with differences in long-term outcome of patients undergoing haemodialysis, both in terms of morbidity and mortality. In the majority of dialysis units, synthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dbe698b132efbdf5a74e0127744f6e8
https://pubmed.ncbi.nlm.nih.gov/27046088
https://pubmed.ncbi.nlm.nih.gov/27046088
Autor:
Boris Schmitz, Johannes Krämer, Jörg Stypmann, Sima Canaan-Kühl, Daniela Blaschke, Stefanie Reiermann, Thomas Duning, Christine Kurschat, Stefan-Martin Brand, Eva Brand, Christoph Wanner, Frank Weidemann, Malte Lenders
Publikováno v:
Orphanet Journal of Rare Diseases
Background Fabry disease (FD) is an X-linked multisystemic disorder with a heterogeneous phenotype. Especially atypical or late-onset type 2 phenotypes present a therapeutical dilemma. Methods To determine the clinical impact of the alpha-Galactosida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a119897e759d9b07751600c982797fee
https://pubmed.ncbi.nlm.nih.gov/27142856
https://pubmed.ncbi.nlm.nih.gov/27142856
Autor:
Holger Reinecke, Stefan Reuter, Barbara Suwelack, Katharina Schütte-Nütgen, Stefanie Reiermann, Hermann Pavenstädt, Rene Schmidt, Viola Malyar
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0161927 (2016)
PLoS ONE
PLoS ONE
Background Cardiovascular disease (CVD) is the leading cause of death after renal transplantation with a high prevalence in dialysis patients. It is still a matter of debate how to assess the cardiovascular risk in kidney transplant candidates. Sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7661fae42acac1c85b2620d205c24ac
http://europepmc.org/articles/PMC5074508?pdf=render
http://europepmc.org/articles/PMC5074508?pdf=render
Autor:
Hermann Pavenstaedt, Martin Hausberg, Uta Hillebrand, Valerie Bartels, Detlef Lang, Stefanie Reiermann, Markus Kosch, Giovana Seno Di Marco, Klaus Kisters
Publikováno v:
American Journal of Nephrology. 36:355-361
Background/Aims: Recent retrospective studies suggest an association of therapy with erythropoiesis-stimulating agents (ESAs) and increased mortality in renal transplant recipients (RTR). Large artery structure and function are significantly impaired
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::671ebf88b75c4b765c9ada6ac6b25591
https://doi.org/10.1159/000343140
https://doi.org/10.1159/000343140
Autor:
Magdalena Woznowski, Lisa Rybicki, Bernd Hoppe, Karl Lhotta, Hartmut P. H. Neumann, Andreas Bock, Ariana Gaspert, Ludwig Patzer, Thomas Fehr, Thorsten Wiech, Gani Berisha, Maren Sullivan, Angelica Malinoc, Oemer-Necmi Goek, Charis Eng, Martin Zeier, Stefanie Reiermann, Klaus Arbeiter, Hannah Linke, Aurelia Winter, Klemens Budde, Michael M. Hoffmann
Publikováno v:
Annals of Human Genetics. 75:639-647
Hereditary atypical hemolytic uremic syndrome (aHUS), a dramatic disease frequently leading to dialysis, is associated with germline mutations of the CFH, CD46, or CFI genes. After identification of the mutation in an affected aHUS patient, single-si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1d2c75f4b0ca4d16bc4f3f945f05142
https://doi.org/10.1111/j.1469-1809.2011.00671.x
https://doi.org/10.1111/j.1469-1809.2011.00671.x